Laparoscopic Hernia Repair for Hiatal Hernia
(PEHFLIP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether some patients can skip fundoplication during laparoscopic paraesophageal hernia repair. Fundoplication is often added to prevent acid reflux, but it might not be necessary for everyone. The trial targets individuals undergoing this hernia surgery for the first time who do not have severe reflux issues. Participants will help determine who truly needs the extra step. As an unphased trial, it offers participants the chance to contribute to personalized surgical approaches and potentially avoid unnecessary procedures.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that laparoscopic paraesophageal hernia repair without fundoplication is safe?
Research has shown that laparoscopic paraesophageal hernia repair without fundoplication is generally safe for patients. One study found that about 25% of patients experienced early swallowing difficulties, but these issues resolved over time. Another report indicated that over 91% of patients had very good early results, with no increased risk of complications or hospital readmission within 30 days. These findings suggest that the procedure is well-tolerated and not associated with significant negative effects.12345
Why are researchers excited about this trial?
Unlike the standard treatment for hiatal hernia, which often includes fundoplication, the laparoscopic paraesophageal hernia repair being studied skips this step. Fundoplication involves wrapping the top of the stomach around the lower esophagus to prevent acid reflux, but it can lead to complications like difficulty swallowing. This new approach aims to repair the hernia without altering stomach anatomy, potentially reducing post-surgery issues while still effectively addressing the hernia. Researchers are excited because it could offer a less invasive option with fewer side effects, improving patient comfort and recovery time.
What evidence suggests that laparoscopic paraesophageal hernia repair without fundoplication is effective for hiatal hernia?
This trial will compare two approaches to laparoscopic paraesophageal hernia repair: one with fundoplication and one without. Research has shown that repairing a paraesophageal hernia using minimally invasive surgery, without adding fundoplication, can be effective. One study found that this surgery leads to excellent results and a short hospital stay when performed at experienced centers. Another study suggested that skipping fundoplication does not increase the risk of issues like acid reflux, which fundoplication is meant to prevent. However, there is a higher chance of the hernia returning, with up to 23% of patients needing another surgery. Despite this, the recurrence doesn't seem to affect long-term function for most patients. Overall, this approach might be a good option for some, but it's important to consider the possibility of needing another procedure.36789
Who Is on the Research Team?
Christy M Dunst, MD
Principal Investigator
The Oregon Clinic
Are You a Good Fit for This Trial?
This trial is for patients who need surgery to fix a paraesophageal hernia but haven't had this type of surgery before. They shouldn't have GERD (acid reflux) diagnosed by tests or a weak valve between the stomach and esophagus found during surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo laparoscopic paraesophageal hernia repair with or without fundoplication based on randomization
Follow-up
Participants are monitored for GERD and hernia recurrence through endoscopic evaluation and pH testing
What Are the Treatments Tested in This Trial?
Interventions
- Laparoscopic paraesophageal hernia repair without fundoplication
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Foundation for Surgical Innovation and Education
Lead Sponsor